Literature DB >> 23172614

Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology.

Sofie Isebaert1, Laura Van den Bergh, Karin Haustermans, Steven Joniau, Evelyne Lerut, Liesbeth De Wever, Frederik De Keyzer, Tom Budiharto, Pieter Slagmolen, Hendrik Van Poppel, Raymond Oyen.   

Abstract

PURPOSE: To prospectively evaluate multiparametric magnetic resonance imaging (MRI) for accurate localization of intraprostatic tumor nodules, with whole-mount histopathology as the gold standard.
MATERIALS AND METHODS: Seventy-five patients with biopsy-proven, intermediate, and high-risk prostate cancer underwent preoperative T2-weighted (T2w), dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) MRI at 1.5T. Localization of suspicious lesions was recorded for each of 24 standardized regions of interest on the different MR images and correlated with the pathologic findings. Generalized estimating equations (GEE) were used to estimate the sensitivity, specificity, accuracy, positive, and negative predictive value for every MRI modality, as well as to evaluate the influence of Gleason score and pT-stage. Tumor volume measurements on histopathological specimens were correlated with those on the different MR modalities (Pearson correlation).
RESULTS: DW MRI had the highest sensitivity for tumor localization (31.1% vs. 27.4% vs. 44.5% for T2w, DCE, and DW MRI, respectively; P < 0.005), with more aggressive or more advanced tumors being more easily detected with this imaging modality. Significantly higher sensitivity values were obtained for the combination of T2w, DCE, and DW MRI (58.8%) as compared to each modality alone or any combination of two modalities (P < 0.0001). Tumor volume can most accurately be assessed by means of DW MRI (r = 0.75; P < 0.0001).
CONCLUSION: Combining T2w, DCE, and DW imaging significantly improves prostate cancer localization.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23172614     DOI: 10.1002/jmri.23938

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  52 in total

1.  Restriction spectrum imaging improves MRI-based prostate cancer detection.

Authors:  Kevin C McCammack; Natalie M Schenker-Ahmed; Nathan S White; Shaun R Best; Robert M Marks; Jared Heimbigner; Christopher J Kane; J Kellogg Parsons; Joshua M Kuperman; Hauke Bartsch; Rahul S Desikan; Rebecca A Rakow-Penner; Michael A Liss; Daniel J A Margolis; Steven S Raman; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  Abdom Radiol (NY)       Date:  2016-05

2.  Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate.

Authors:  Aritrick Chatterjee; Sevil Tokdemir; Alexander J Gallan; Ambereen Yousuf; Tatjana Antic; Gregory S Karczmar; Aytekin Oto
Journal:  AJR Am J Roentgenol       Date:  2018-11-07       Impact factor: 3.959

Review 3.  Addressing the need for repeat prostate biopsy: new technology and approaches.

Authors:  Michael L Blute; E Jason Abel; Tracy M Downs; Frederick Kelcz; David F Jarrard
Journal:  Nat Rev Urol       Date:  2015-07-14       Impact factor: 14.432

4.  Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience.

Authors:  Arjun Sivaraman; Rafael Sanchez-Salas; Eric Barret; Petr Macek; Pierre Validire; Marc Galiano; Francois Rozet; Xavier Cathelineau
Journal:  World J Urol       Date:  2014-12-12       Impact factor: 4.226

5.  Quantitative evaluation of diffusion-weighted imaging techniques for the purposes of radiotherapy planning in the prostate.

Authors:  G P Liney; L Holloway; T M Al Harthi; M Sidhom; D Moses; E Juresic; R Rai; D J Manton
Journal:  Br J Radiol       Date:  2015-03-05       Impact factor: 3.039

6.  Classification of suspicious lesions on prostate multiparametric MRI using machine learning.

Authors:  Deukwoo Kwon; Isildinha M Reis; Adrian L Breto; Yohann Tschudi; Nicole Gautney; Olmo Zavala-Romero; Christopher Lopez; John C Ford; Sanoj Punnen; Alan Pollack; Radka Stoyanova
Journal:  J Med Imaging (Bellingham)       Date:  2018-09-06

Review 7.  Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Authors:  Ryan L Brunsing; Natalie M Schenker-Ahmed; Nathan S White; J Kellogg Parsons; Christopher Kane; Joshua Kuperman; Hauke Bartsch; Andrew Karim Kader; Rebecca Rakow-Penner; Tyler M Seibert; Daniel Margolis; Steven S Raman; Carrie R McDonald; Nikdokht Farid; Santosh Kesari; Donna Hansel; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

8.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

9.  An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiation Therapy Boost Volumes.

Authors:  Radka Stoyanova; Felix Chinea; Deukwoo Kwon; Isildinha M Reis; Yohann Tschudi; Nestor A Parra; Adrian L Breto; Kyle R Padgett; Alan Dal Pra; Matthew C Abramowitz; Oleksandr N Kryvenko; Sanoj Punnen; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-13       Impact factor: 7.038

10.  Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Authors:  Anwar R Padhani; Jeffrey Weinreb; Andrew B Rosenkrantz; Geert Villeirs; Baris Turkbey; Jelle Barentsz
Journal:  Eur Urol       Date:  2018-06-13       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.